Navigation Links
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Date:8/19/2007

SEATTLE, Aug. 17 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced publication of results from a Phase 1 study of NEUVENGE, an investigational active cellular immunotherapy, in the August 20 issue of the Journal of Clinical Oncology. The article highlights the safety profile, immune response and clinical activity of NEUVENGE in women with HER2/neu-positive breast cancer who have failed standard therapy.

"In addition to demonstrating that NEUVENGE was safe and well tolerated, the T-cell responses seen in these patients and the prolonged disease stabilization in the absence of other anti-cancer therapies in many patients is promising," said John W. Park, M.D., associate clinical professor of medicine and neurosurgery at the University of California, San Francisco and lead author of the publication. "These observations are encouraging and are suggestive of the clinical benefit of NEUVENGE, particularly in light of the aggressive cancer seen in these patients who had progressed while on standard therapy. The findings warrant additional studies of NEUVENGE for the many women with advanced breast cancer who have exhausted many of their treatment options."

Study Design

The Phase 1 study (D2000-2) was conducted to evaluate the safety and immunologic activity of NEUVENGE in patients with HER2-overexpressing metastatic breast cancer who had failed standard therapy, including prior treatment with chemotherapy and trastuzumab. All patients had experienced disease progression while on standard therapy. There were 19 patients enrolled in the study with 18 patients receiving treatment with NEUVENGE. Patients underwent three infusions of NEUVENGE at Weeks 0, 2, and 4 following randomizati
'/>"/>

SOURCE Dendreon Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... , Nov. 17, 2014 Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today the formation of a Medical ... to the Company as it advances the Phase ... the treatment of cutaneous T-cell lymphoma (CTCL), a ...
(Date:11/16/2014)... Rowley, MA (PRWEB) November 16, 2014 ... University's Renovation With Filtered Fume Hoods, 3 Years Later” ... In the fall of 2011, Butler University surprised many ... fume hoods in their organic chemistry and general chemistry ... several shortcomings due to building age and substantial growth ...
(Date:11/15/2014)... 14, 2014 As part of ... significant investments in its network and logistics capabilities ... chain and the complex requirements of the industry. ... on customized logistics and transportation, and includes opening ... facilities. There will be an emphasis on Customer ...
(Date:11/15/2014)... Gilbert, Arizona (PRWEB) November 14, 2014 ... Research , ‘ISCTR’ announced today that the society’s ... Stanton J. Rowe, Edwards Lifesciences chief scientific officer ... Affairs, chief medical officer, Abbott Vascular. Mr. ... leaders and medical device development experts. , ...
Breaking Biology Technology:Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 2Don't miss the I2SL High-Tech Talks Webinar Series Presenting: Butler University's Renovation With Filtered Fume Hoods, 3 Years Later 3QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2International Society for Cardiovascular Translational Research Governing Board Adds Medical Industry Leaders 2
... - There are several reasons why Deb Rislow believes she ... of information systems for Gundersen Lutheran - at ... been a hotter topic as the federal government tries to ... to reduce medical errors, control costs, and improve care. , ...
... It would be impressive enough if the robotics engineering ... Park, Minn., had won a national championship against other ... competitors were seasoned college students. , ,Led by instructor ... graduate-level college students in the 2005 U.S. Open RoboCup. ...
... the United States Supreme Court strengthened the case ... Foundation? , ,The answer is yes, according to the California ... not necessarily a consensus opinion. , ,The nation's high court, ... Appeals for the Federal Circuit , ruled in favor of ...
Cached Biology Technology:CIO Leadership Series: Deb Rislow, Gundersen Lutheran 2CIO Leadership Series: Deb Rislow, Gundersen Lutheran 3CIO Leadership Series: Deb Rislow, Gundersen Lutheran 4CIO Leadership Series: Deb Rislow, Gundersen Lutheran 5Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4Supreme Court ruling seen as blow to WARF stem cell patents 2Supreme Court ruling seen as blow to WARF stem cell patents 3
(Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
(Date:11/15/2014)... , Nov. 13, 2014  While we may still ... Doctor McCoy used in "Star Trek" to gain instant access ... designed to work with smartphones and tablets for monitoring and ... the healthcare world. This may seem a tad Orwellian to ... to adopt some of these technological opportunities into their healthcare ...
(Date:11/7/2014)... led by Dr. Debra Auguste, associate professor, biomedical ... The City College of New York, have identified ... for one of the most aggressive forms of ... have a high mortality rate owing to aggressive ... therapeutic options. However, Professor Auguste,s team, discovered the ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... allowed patients suffering from musculoskeletal conditions such as hip ... pain-free. But some "high risk" surgical devices that have ... (FDA) are not required to go through clinical trials, ... and effectiveness. "This could be potentially very dangerous. ...
... could provide the link that scientists have been looking for ... a cause of some heart problems. Looking at blood ... found that those who had suffered a heart attack were ... blood compared to patients with less acute symptoms. And having ...
... of silicon react with water to produce hydrogen almost ... a series of experiments, the scientists created spherical silicon ... water, these particles reacted to form silicic acid (a ... energy for fuel cells. The reaction didn,t require ...
Cached Biology News:A call to prevent unsafe high-risk medical devices from reaching the marketplace 2A call to prevent unsafe high-risk medical devices from reaching the marketplace 3Study: Viral reactivation a likely link between stress and heart disease 2Study: Viral reactivation a likely link between stress and heart disease 3Just add water: How scientists are using silicon to produce hydrogen on demand 2
...
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 21 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
... the experimental process of determining the nucleotide ... DNA Sequencing is based on Sangers enzymatic ... allows cycle sequencing reactions. The resulting fluorescent ... capillary instrument controlled by a computer and ...
... On-Demand Cytometry The Guava EasyCyte system ... based multiparameter cytometer with built-in 96-well microplate ... screen plates of cells and compounds quickly ... multiple tubes or having the carryover issues ...
Biology Products: